71 / 80
56
A.
Jimenez-Aceituna
et al.
/ Cir Cardiov. 2016;
23(1)
:53–56
2.
Garcia delBlanco
B,
Rumoroso Cuevas JR, Hernandez Hernandez F, Trillo Nouche R. Registroe sp a˜nol de Hemodinamica y CardiologiaI ntervencionista XXII informe oficial de la seccion de hemodinamica y cardiologia intervencionista de la
Socie- dad esp a˜nola de Cardiologia (1990-2012). Rev
Esp Cardiol.
2013;66(11):894– 904.
3.
Amanullah MM, SiddiquiMT, Khan MZ, Atiq MA. Surgical Rescue of embolized Amplatzer devices. J Card Surg. 2011;26:254 –8.
4.
Chessa M, CarminatiM, Butera G, Bini
RM, Drago M, Rosti L, et
al. Early and Late complications associated with trascatheter oclusion af secundum atrial septal defect. J Am
Coll Cardiol. 2002;39:1061 –5.
5.
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Associa- tionTask Force on Practice
Guidelines (Writing
Committee to Develop Guidelines on the Management ofA dults WithC ongenital Heart Disease). Developed inc olla- boration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovas- cular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1
–
121.6.
Reddy VY, Holmes D, Doshi SK, NeuzilP,
Kar S. Safety of percutaneous left
atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access
Registry.
Circulation. 2011;123:417 –24.